Technological Vanguard: The Ascendancy of Next-Generation Sequencing (NGS) as the Definitive Platform for Oncology Companion Diagnostics
  The technological landscape of companion diagnostics is undergoing a rapid evolution, with Next-Generation Sequencing (NGS) emerging as the dominant and most sophisticated platform, displacing many of the single-gene or single-protein assays that characterized the market's early phase. Traditional technologies like Polymerase Chain Reaction (PCR) and Fluorescence In Situ Hybridization...
0 Comentários 0 Compartilhamentos 49 Visualizações 0 Anterior